For example, a study demonstrated that remodeling of the ECM in adipose and muscle tissue plays a pivotal role in metabolic disease development, identifying genes such as TCF7L2, ADIPOQ, CD36, PPARG, IL6, SIRT1, and COL5A1 as key regulators of inflammation [214]. This evidence concerns the gene TCF7L2 and metabolic disease.